Barriers to Transplantation

Similar documents
Living Donor Paired Exchange (LDPE)

Highly Sensitized Patient Registry: Update and Successes

Paired Donation. Andrew Bradley Rachel Johnson Joanne Allen Susan V Fuggle. Cambridge University NHS Hospitals NHS Foundation trust

Renal Transplant Past Present and Future David Landsberg

UCLA Kidney Exchange. An option for patients with incompatible living donors

DONATION & TRANSPLANTATION. Interprovincial. Programs Report

Welcome to Your DSA Action Team Meeting. February 29, 2012

Overview of organ donation and transplantation

Transplant Options for Patients: Choices and Consequences. Olwyn Johnston Medical Director Kidney Transplantation Vancouver General Hospital

Update on organ donation in British Columbia

Donation and Transplantation Kidney Paired Donation Program Data Report

Commonly Asked Questions about Kidney Transplants

LUNG ALLOCATION SCORE SYSTEM UPDATE

9/30/2016. Chris E. Freise, MD Professor of Surgery UCSF Transplant Division

Green Light to Transplant: A Stepwise Approach

Donation & Transplantation Interprovincial Programs Report

The New Kidney Allocation System: What You Need to Know. Anup Patel, MD Clinical Director Renal and Pancreas Transplant Division Barnabas Health

Oxford Transplant Centre. Live donor kidney transplantation what if we are not a match?

ABO mismatched Renal Transplants

STEP-programme S-candiaT-ransplant kidney E-xchange P-rogramme (STEP) Version 1.8

TA L K I N G A B O U T T R A N S P L A N TAT I O N

Georgia Regents. Kidney and Pancreas Transplant Program. Welcome!

Organ Donation Breakthrough Collaborative Institute of Medicine

Paired Exchange Results Quarterly Report

A Guide to Better Living

HIV POSITIVE YOUTH: LINKAGE & RETENTION IN CARE

About kidney transplant care in New Zealand

Chapter 9. Kidney Donors. ANZDATA Registry 37th Annual Report. Data to 31-Dec-2013

Transplantation in Australia and New Zealand

Directed altruistic donation dilemmas: a transplant surgeon s perspective

New Ways to Tackle a Growing Health Care Dilemma - ESRD

Transfusion support in Transplantation

East London Community Kidney Service

U.S. changes in Kidney Allocation

NHSBT Board July Update on UK Living Kidney Sharing Scheme

HAVING HOPE: how plasma exchange is helping more organ transplant patients BY LORI ALEXANDER, AABB CONTRIBUTING WRITER AT

End Stage Renal Disease (ESRD) Network Learning and Action Network (LAN) Series: Bloodstream Infection (BSI) Quality Improvement Activity

The number of patients registered on the kidney transplant list this year fell by 7% from 5686 to 5275

Strategies for Desensitization

The number of patients registered on the kidney transplant list this year fell by 4% from 5,233 to 5,033

Are Your Patients Well Prepared for Kidney Transplant?

Getting a New Kidney UHN. Information for patients and families. Is a kidney transplant right for me? Read this booklet to learn:

Social deprivation, ethnicity and access to kidney transplantation in England and Wales. Udaya Udayaraj

Chi-Square Goodness-of-Fit Test

Living Kidney Donation. Dr. Joseph Keith Melancon

Guide to Transplantation and Living Donation

STRENGTHENING THE COORDINATION, DELIVERY AND MONITORING OF HIV AND AIDS SERVICES IN MALAWI THROUGH FAITH-BASED INSTITUTIONS.

Why so Sensitive? Desensitizing Protocols for Living Donor Kidney Transplantation

City of Vancouver s Response to the Opioid Crisis Fire Chief Darrell Reid Vancouver Fire & Rescue Services (VF&RS)

The New Kidney Allocation Policy: Implications for Your Patients and Your Practice

Empowering Our Communities:

Implementing Rapid Response Teams (RRT) National Call September 13, 2007

East of Scotland Renal Transplantation Service. Annual Report. The Royal Infirmary of Edinburgh

Transplantation in 2012:

Organ Procurement and Transplantation Network

Frequently Asked Questions about Kidney Transplantation

Update on Kidney Allocation

Flu Watch. MMWR Week 3: January 14 to January 20, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance

Welcome KATHY SCHWAB, DSA ACTION TEAM CHAIR. Compliance Coordinator, Mayo Clinic Transplant Center

New Zealand Kidney Allocation Scheme

Organ Donation & Allocation. Nance Conney Thomas E. Starzl Transplantation Institute

FAQs about Provider Profiles on Breast Cancer Screenings (Mammography) Q: Who receives a profile on breast cancer screenings (mammograms)?

Consultant-led Referral to Treatment (RTT) waiting times collection timetable: outcome of consultation

Chapter 9. Kidney Donors. ANZDATA Registry 39th Annual Report. Data to 31-Dec-2015

ANNUAL REPORT The Norwegian Renal Registry. (Norsk Nefrologiregister)

University of Pittsburgh Critical Care Medicine

End Stage Kidney Disease Among Indigenous Peoples of Australia and New Zealand

Thanks to our Speakers!

Flu Watch. MMWR Week 4: January 21 to January 27, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance

Manchester Royal Infirmary Renal & Pancreas Transplant Unit / 2012 Activity Annual Report

Chest x-ray Cardiovascular tests (EKG, echocardiogram, angiogram, stress test) Upper and lower G.I. (gastrointestinal) tests Blood tests

Chapter 7. Australian Waiting List. ANZDATA Registry 39th Annual Report. Data to 31-Dec-2015

Annual Statistics on Organ Replacement in Canada

Nurse-led Rapid Access Chest Pain Clinic at the Royal Glamorgan Hospital. by Sharon Cassidy/Andrea Gasson

Finding a Living Donor: A RESOURCE GUIDE

Finding a Living Donor: A RESOURCE GUIDE

Living Donor Kidney Transplant

Types of living donor transplants

ANNUAL REPORT The Norwegian Renal Registry. (Norsk Nefrologiregister)

Glossary. Anesthesiologist A doctor who puts you or parts of your body to sleep during surgery.

NHS BLOOD AND TRANSPLANT KIDNEY OFFERING SCHEME WORKING GROUP ENDORSEMENT OF A NEW NATIONAL KIDNEY OFFERING SCHEME

Blood Component Testing and Labeling

CHAPTER 12 END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND. Stephen McDonald. Matthew Jose. Kylie Hurst INDIGENOUS 12-1

Blood Supply and Wastage

Older Living Kidney Donors and Recipients. Charles Le University of Colorado 6/24/11

KIDNEY TRANSPLANT - A TREATMENT OPTION

Transplants at University Hospital. Kidneys. Normal Kidneys

Waiting for a Kidney. Objectives

ANNUAL REPORT The Norwegian Renal Registry. (Norsk Nefrologiregister)

What Happens on Call?? June 02, 2016

Embracing the Magic: Increasing Organ Acceptance Rates Through Data Review and Risk Stratification

KPD transplants. Dutch Experience. Korean experience. NEAD chain

Evaluation Process for Liver Transplant Candidates

Desensitization in Kidney Transplant. James Cooper, MD Assistant Professor, Kidney and Pancreas Transplant Program, Renal Division, UC Denver

Final Report: Update on Prior Living Donors Who Were Subsequently Placed on the Waiting List

Keeping your options open. Transplant In Center Hemodialysis Home Hemodialysis Peritoneal dialysis No dialysis

IMPLEMENTING RECOVERY ORIENTED CLINICAL SERVICES IN OPIOID TREATMENT PROGRAMS PILOT UPDATE. A Clinical Quality Improvement Program

Allocation of deceased donor kidneys. Phil Clayton NSW Renal Group 14 June 2012

Renal Transplantation: Allocation challenges and changes. Renal Transplantation. The Numbers 1/13/2014

Transcription:

Barriers to Transplantation Ruth McCarrell RN BSN CNeph(C) Clinical Nurse Leader Kidney transplant Program St. Paul s Hospital Email: rmccarrell@providencehealth.bc.ca

Overview Transplant Basics Living Donor vs Deceased Donor Transplant Referral and assessment processes Barriers to Transplant Strategies to decrease the barriers

Transplant Referral & Assessment Primary Nephrologist completes baseline testing Transplant referral not too early / too late Transplant Assessment when: A living donor is in work up Highly sensitized Predicted to be within 2 years of DDTx

Types of Kidney Transplants Deceased Donor Transplant with allocation by: Blood type, dialysis waiting time, age appropriate kidney Living Donor Transplant Direct Donation (includes OOP and OOC) Living Donor Paired Exchange Program (LDPE) Non-directed Anonymous Donor (NDAD)

Blood Type Compatibility A Recipient of blood type. A Is compatible with a Donor of blood type. A or O B B or O AB A, B, AB or O O O The Rh Factor (+ or -) is NOT Important for Kidney Transplant

Immunology Testing Tissue Typing (blood sample) Identifies genetic make up Tells how genetically similar/dissimilar a recipient is to the donor Antibody identification Identifies Recipient sensitivities Commonly sensitized through blood transfusions, pregnancy, or previous transplant Crossmatch Ensures no reaction between recipient and donor blood specimens A predictor of kidney rejection

BC Transplant Stats British Columbia Totals Year Live donors Deceased Total Donors 2006 101 63 164 2007 106 66 172 2008 80 87 167 2009 89 56 145 2010 97 92 189 2011 98 93 191 2012 (to-date Oct 9, 2012) 58 92 150

Average Wait Times for First Deceased Donor Transplant Year of Transplant Years Months 2011 5.2 62.2 2010 5.3 63.1 2008 5.7 68.4 2007 6.1 73.7 2006 6.7 80.9 2005 5.7 68.9 www.transplant.bc.ca

Adult Average Wait Times (in Years) by Blood Type for First Deceased Donor Transplant Year Type A Type B Type AB Type O 2011 2.7 6.2 1.9 5.9 2010 3.4 5.6 3.7 6.5 2009 2.3 7.7 4.9 6.6 2008 4.0 n/a 3.2 6.9 2007 4.9 7.3 2.6 6.8 2006 4.7 7.2 n/a 7.1 2005 4.6 5.7 3.7 6.7 www.transplant.bc.ca

Deceased Donor Blood Group 2002-2011

Why Living Donation Living donor kidney transplantation is an accepted and preferred treatment option for people with kidney disease Advantages include: Better success rates Recipient can avoid long wait times Can be planned before starting dialysis (pre-emptive transplant)

Graft Survival and Year of Transplant

Graft Survival and Year of Transplant

Relationship of Living Donor to Recipient in BC Relation 2007 2008 2009 2010 2011 2012 Oct 9/12 Total Related vs Unrelated Biologically Unrelated 18 16 23 36 30 24 147 147 Sibling Spouse Parent Offspring Other Biologically Related 28 23 19 19 25 7 121 19 18 20 13 21 9 100 380 21 13 13 10 10 5 72 12 8 12 11 6 10 59 8 2 2 8 6 2 28 www.transplant.bc.ca

Living Donor Paired Exchange Program For pairs where direct donation is not possible Incompatible blood type Positive cross match donor Started in January 2009 Managed by Canadian Blood Services Now a Canada-wide program

Types of Exchanges Closed Chain (Paired Exchange) Domino Chain Closed Chain (Multiple Pairs) 16

LDPE Current Stats

Non-Directed Anonymous Donor (NDAD) Willing to give to an unknown recipient Testing is the same as other living donors In addition: Must be at least 25 years old Has a psychological assessment Not able to influence the Recipient selection Donates: Directly to the waitlist helps one person Through LDPE Program triggers multiple transplants

Barriers to Transplant Too early/too sick Blood Type Longer wait times for some Highly sensititized - PRA No Living Donor

Case Study #1 T.M., 52 years, ABO: O, PRA: 0% Dx: Focal, proliferative Glomerulonephritis Etiology unknown Feb 2004: Registered in KFC Mar 2008: Transplant Referral Cr: 501 egfr: 11 Apr 2008: One donor registered May 2008: Seen and approved for Tx

Case Study #1(cont) Barrier: Blood type: O Current wait for DDTX: 6.9 years May 2008: Attended Tx education session with 4 family members. 1 Donor previously registered, following TX education 4 more donors registered and started work up. When the first donor was declined another was able to quickly complete their assessment. July 2008: Pre-emptive LDTx Strategies: Early enough referral for pre-emptive Tx, Early Tx Education, Multiple Donors in work up

Case Study #2 M.J., 66 years, ABO: O, PRA: 0% Dx: Nephropathy caused by drug toxicity Mar 2000: Registered in KFC Sept 2007: Referred to Tx Cr: 260 egfr: 16 No Living Donors identified Barriers: Blood type: O, No Living Donors Current wait time for DDTx: 6.8 years

Case Study #2 (cont) Oct 2009: Met with Tx Social Worker to discuss donor outreach, sample letters given and family was written to Dec 2009: Living Donor registered and started work up Jan 2010: Transplant assessment Apr 2010: Approved for LDTx Jun 2010: Pre-emptive LDTX Strategies: LD outreach, tools included recipient education, coaching, donor sample letters

Case Study # 3 S.S., 40 years, ABO: B DX: Lupus Erythematous PRA: 80-93% Sensitization history: Pregnancies, blood transfusions, autoimmune disorder Oct 2006: Referred to KFC Dec 2006: Dialysis start date & Referred to Tx currently medically unsuitable Dec 2008: Approved for Tx Activated to DDTx Wait list Current wait time for B DDTX: 7.2 Wait time for S.S. unknown due to PRA

Case Study # 3 (cont) Feb 2007 Apr 2009: 45 Donors registered All declined medical, wrong blood type, crossmatch positive Barriers: Blood type: B, PRA Strategies: Activation to highly sensitized WL, Continue outreach to donors: family, friends, social/work groups New initiative Jan 2009: LDPE Program started S.S. Immediately registered with spouse (Blood type: O) Initial LDPE enrollment numbers were small. High PRA remained a challenge. Sep 2010: Received LDPE proposal. Nov 2010: LDPE LDTx, Donor travelled OOP for donation

LDPE Domino Proposal NDAD ABO: O Travel: No Paired Donor ABO: O Travel: Yes Paired Donor ABO: A Travel: Yes Recip: SS ABO: B PRA: 93% Recip: OOP ABO: O PRA: 0% Recip: BC WL ABO: A PRA: 9%

Case Study #4 S.C., 51 years, ABO: O Dx: Membranous glomerulonephropathy PRA: 89% Sensitization history: 3 previous transplants May 2011: Referred to Tx failing graft Cr: 328 egfr:18 Registered Blood Type O, crossmatch positive donor Dec 2011: approved for LDTx

Case Study #4 (cont) Barriers: Eligibility for 4 th DDTx, PRA, Incompatible living donor Strategy: Jan 2012: Registered in LDPE Program with incompatible donor Feb 2012: LDPE proposal August 2012: Pre-emptive 4 th Tx

Case Study #4 LDPE Chain Paired Donor ABO: A Travel: Yes Paired Donor ABO: O Travel: Yes Paired Donor ABO: O Travel: Yes Recip: OOP ABO: A PRA: 99% Recip: SC ABO: O PRA: 89% Recip: OOP ABO: O PRA: 19%

Case Study #5 D.C., 67 years, ABO: A Dx: Type II Diabetes, HTN PRA: 89% Sensitization: 5 Pregnancies Dialysis start date: Aug 2006 Initially did well on PD. Developed increasing complications. Geographically not near HD unit Referred to Tx: Oct 2010 Oct 2010: Living donor (spouse) registered ABO O but crossmatch positive Dec 2010: TX assessment Required cardiac and respiratory work up

Case Study #5 (cont) Feb 2011: Approved for Tx Incompatible LD also approved Current Wait time for DDTX unknown due to PRA Barriers: PRA, Crossmatch positive LD, Medical testing to be completed Strategy: List in LDPE Program Mar 2011: LDPE proposal Jul 2011: LDPE LDTx

Case Study #5 LDPE Chain Paired Donor Lives OOP ABO: A Travel: Yes Paired Donor ABO: O Travel: No Paired Donor ABO: O Travel: Yes Paired Donor ABO: A Travel: Yes Recip: DC (SPH) ABO: A PRA: 89% Recip: SPH #2 ABO: O PRA:45 % Recip: OOP ABO: B PRA: 56% Recip: VGH ABO: O PRA: 96%

Case Study # 6 S.W., Age: 38 years, ABO: O, PRA: 0% Dx: Polycystic Kidney Disease Aug 2006: Referred to Tx Cr 259 egfr: 24 (early) May 2009: Suitable for LD Tx May 2009: 1 Donor ABO: A2 - Incompatible May 2009: Registered in LDPE Program

Case Study #6 (cont) Barrier: ABO incompatible donor, No immediate match in LDPE Program Strategy: Investigate Anti-a titre and if low consider ABO incompatible Tx Low Anti- A titre: Desensitization with plasma exchange and Rituximab pre- LDTx Jul 2009: ABO incompatible LDTX

Keep Options Open LD Direct Donation Will consider OOP/OOC OOC donor work ups will be slower and can be more costly Multiple donors can come forward at once LDPE Paired Exchange If approved incompatible donor Deceased Donor Wait List Wait times longer for some blood types ABO Incompatible donation Suitable for small number

Successful Strategies Bring family and friends to education sessions Provide Donor outreach tools Sample letters Importance of LDPE A large donor pool Register more than one donor if different characteristics Consider for multiple repeat transplant Revisit Transplant option if dialysis no longer optimal

Transplant Education Tools coming soon. Recipient and Living Donor brochures Online videos Lets talk about Kidney transplant..

Questions???? Contact: Ruth McCarrell RN BSN CNeph(C) Clinical Nurse Leader Kidney Transplant Program St. Paul s Hospital Email: rmccarrell@providencehealth.bc.ca